Review Article

Adjuvant Treatment of Melanoma

Figure 2

Joint analysis of the E1683 and E1690 studies recurrence-free survival/overall survival [33]. Proven benefits in relapse-free survival (HR: 1.30; ), but not in overall survival.
545631.fig.002a
(a)
545631.fig.002b
(b)